Hello gang! 

 

ACUS is a MA "bio stock" that I invest in.  Some here have seen me defend this stock on another board with a very unsavory character.  This company has a resin sphere that encases a gas.  The spheres are about one-third the size of a red-blood cell.

 

The spheres can be injected into the blood and aid in the diagnosis of clogged arteries.  They are used with "echo" (ultrasound).  Currently patients with signs of clogged arteries generally are tested using nuclear imaging and angiograms and only if they have symptoms. Millions of these tests are done per year. Millions more are not because of the cost and lack of symptoms (screening).  These current tests are lengthy, expensive, and the equipment is found only at certain locations.  Not to mention using radioactive tracers.

 

The gas in the spheres allow use of "echo" to measure both blood flow and wall motion in the heart.  This gives a potential better diagnosis. This is being tested against imaging and angiograms.

 

It is a potential big advance in diagnosis of cardiac problems.  ACUS has completed enrollment in their Phase III trials (2) (called RAMP I and II).  The first was reported earlier this summer.  They missed on a testing parameter (sensitivity) and the market pummeled them.  The science results were really good though (accuracy more important).  Then the company reported a potential delay in reporting the second study and they got pummeled again.  The market did not understand the heavy analysis that it takes to put together the large amount of data generated (combining studies).

 

I bought at 3.62 and then at 2.40.  It is now back to about 3.40.  It has been creeping upward.  Between the institutions and the insiders, they own 90% of this stock.  They have been adding to their positions, not getting out.  Analysts say possible 8.00-12.00 stock with good results.  There are competitors out there, but all with problems.

 

ACUS is preparing their manufacturing facility, have a partnership with a European company for support, and have licensed some technology from other companies that could have been patent problems.

 

My opinion is that this stock will continue to creep upward for the next 2-3 of months in anticipation of the next trial results.  Then they will report.  If they are good, the stock could really take off.  If they are bad, it could be a giant setback.  It is about crunch time for this company!  Odds are better for this company than other bios.  Still very risky!  Its a risk I am taking!  Check it out-wonderful science!  Amazing stuff!

 

Could be invested in for the creep up in price or the potential pop.  I'm watching closely.  Let me know if anyone wishes to hear more.

 

Kutz